SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Nagaraju R. Arakotaram who wrote (402)6/14/1997 10:28:00 AM
From: Dauntless   of 7041
 
Nagaraju,

Zona is a long term play for me so I try not to get to excited or depressed on short term movement. Also, the float on Zona is very thin so low trading volumes have an exaggerated effect.

However, since you asked - IMHO Zona is (or will shortly be) on the radar screens of major brokerages & institutions. The clinical data is in & looks good. The firms handling the new offering are respected - OK, they're not Smith Barney, etc. - but they are high quality & lend that image to the offering. It would not take much for some big people to decide to take a position - with a big influence on the price. So I guess I'm bullish short term - but I'm even more bullish long term.
Why?

1- Vasomax works for some percentage of the target population.
2- Oral therapies will certainly be the first to be tried by any clear thinking guy.
3- The current offering will enable the company to negotiate from a position of strength for the marketing & distribution rights.
4- Approval & sales in Mexico & So. America could happen this year.
5- The number of shares outstanding is small & the current market valuation is too low.

Enough??? GOOOOoooooo ZOOOOoooooonaaaaaaa
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext